<DOC>
	<DOCNO>NCT00973076</DOCNO>
	<brief_summary>The primary objective ass safety tolerability AZD8055 Japanese patient advance solid tumour .</brief_summary>
	<brief_title>Study Assess Safety Tolerability Tor Kinase Inhibitor AZD8055</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Japanese patient advance solid tumor suitable effective standard treatment exist longer effective Relatively good overall health cancer Poor bone marrow function ( produce enough blood cell ) Poor liver kidney function Serious concomitant illness</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Phase I , cancer</keyword>
	<keyword>solid tumor</keyword>
	<keyword>advanced solid malignancy</keyword>
	<keyword>dose escalation</keyword>
	<keyword>mTOR Kinase Inhibitor</keyword>
	<keyword>Japanese</keyword>
</DOC>